Peri-operative monitoring technology has made great strides in the last 20 years with the introduction of minimally invasive devices to measure inter alia stroke volume, cardiac output, depth of anaesthesia and cerebral and tissue oxygen monitoring. Despite these technological advances, peri-operative management of the high risk major surgery patient has remained virtually unchanged. The vast majority of patients undergo a pre-operative assessment which is neither designed to quantify functional capacity nor predict outcome. Anaesthetists then usually monitor these patients using the same technology (e.g. pulse oximetry (SpO2), invasive systemic BP and CVP, end tidal carbon dioxide (etCO2) and anaesthetic agent monitoring) that was available in the early 1980s. Conventional intra-operative management can result in occult low levels of blood flow and oxygen delivery that lead to complications that only occur days or weeks following surgery and give false re-assurance to the anaesthetist that he or she is doing a "good job". Post-operative management then often takes place in an environment with reduced levels of both monitoring equipment and staff expertise. It is perhaps not surprising that outcome still remains poor in high-risk patients.(1) In this review, we will briefly describe the role of peri-operative optimization, some of the available monitors and indicate how their combined use might be beneficial in managing the high-risk surgical patient. We believe that although there is now evidence to suggest that the use of individual new monitors (such as assessment of fluid status, depth of anaesthesia, tissue oxygenation and blood flow) can influence outcome, it will only be their combination that will radically improve the peri-operative management and outcome of high-risk surgical patients. It is a matter of some urgency that large scale, prospective and collaborative studies be designed, funded and executed to prove or disprove this hypothesis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijsu.2009.12.004 | DOI Listing |
Spine J
January 2025
The Ottawa Hospital - Civic Campus, 1053 Carling Ave, Ottawa, Ontario, Canada, K1Y4E9. Electronic address:
Background Context: Significant variability in the management of Adult Spinal Deformity (ASD) has been observed among spine surgeons worldwide. The variability among Canadian spine surgeons, a country with universal public healthcare, remains unknown.
Purpose: The study aims to evaluate areas of variability in the peri-operative optimization and surgical management of ASD among Canadian spine surgeons.
J Heart Lung Transplant
January 2025
Division of Cardiac Surgery, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, CA. Electronic address:
Background: Genetically engineered porcine hearts may have an application for infants in need of a bridge to cardiac allotransplantation. The current animal model that resulted in 2 human applications has been validated in adult non-human primates only. We sought to create an infant animal model of life sustaining cardiac xenotransplantation to understand limitations specific to this age group.
View Article and Find Full Text PDFAnaesthesia
January 2025
Department of Anesthesiology, Critical Care and Pain Management, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, USA.
Background: Demand for total hip and knee arthroplasty procedures continues to rise. Ongoing changes in surgical care and patient populations require continued monitoring of outcome trends. Using nationwide data from the USA, we aimed to describe updated trends in patient and peri-operative care characteristics as well as complications among total hip and knee arthroplasty recipients.
View Article and Find Full Text PDFBJU Int
December 2024
Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy.
Objectives: To evaluate the role of the TYTOCARE™ telemedicine programme for home telemonitoring during the early postoperative period following radical cystectomy (RC) in a prospective single-centre study.
Materials And Methods: The study included patients aged <80 years with internet access who underwent RC at our institution between March 2021 and August 2023. Upon discharge, patients were monitored at home using the TYTOCARE™ telemedicine system.
J Clin Exp Hepatol
November 2024
Institute of Liver Disease & Transplantation, Gleneagles Health City, Chennai, India.
Small-for-size syndrome is a clinical syndrome of early allograft dysfunction usually following living donor liver transplantation due to a mismatch between recipient metabolic and functional requirements and the graft's functional capacity. While graft size relative to the recipient size is the most commonly used parameter to predict risk, small-for-size syndrome is multifactorial and its development depends on a number of inter-dependant factors only some of which are modifiable. Intra-operative monitoring of portal haemodynamics and portal flow modulation is widely recommended though there is wide variation in clinical practice.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!